Risk Based -Post Marketing Surveillance Guidline
Risk Based -Post Marketing Surveillance Guidline
","url":"http:\/\/www.efda.gov.et\/"}},"mobileHeader":{"firstSwitchPoint":990,"secondSwitchPoint":778,"firstSwitchPointHeight":80,"secondSwitchPointHeight":60},"stickyMobileHeaderFirstSwitch":{"logo":{"html":""}},"stickyMobileHeaderSecondSwitch":{"logo":{"html":""}},"content":{"textColor":"#8c95a2","headerColor":"#133d58"},"boxedWidth":"1340px","stripes":{"stripe1":{"textColor":"#dbdbdb","headerColor":"#ff9f1a"},"stripe2":{"textColor":"#333333","headerColor":"#203961"},"stripe3":{"textColor":"#000000","headerColor":"#203961"}}},"VCMobileScreenWidth":"778"};
var dtShare = {"shareButtonText":{"facebook":"Share on Facebook","twitter":"Tweet","pinterest":"Pin it","linkedin":"Share on Linkedin","whatsapp":"Share on Whatsapp","google":"Share on Google Plus"},"overlayOpacity":"85"}; /* ]]> */
Risk Based -Post Marketing Surveillance Guidline
Guideline for Consumer Reporting of ADEs -English Version
Guideline for Consumer Reporting of ADE -l Amharic Version
Sinopharm Covid 19 vaccine active surveillance report
A blueprint for strengthening pharmacovigilance systems in resource limited countries
Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni infected school children in Southern Ethiopia A prospective cohort study